Lung cancer : journal of the International Association for the Study of Lung Cancer
-
Immune checkpoint inhibitors (ICIs) can cause pneumonitis in lung cancer patients. We aimed to identify the clinical and radiologic characteristics, incidence, and risk factors of ICI-related pneumonitis in patients with non-small cell lung cancer (NSCLC). ⋯ ICIs should be used with caution when treating lung cancer patients who have underlying chronic lung disease, especially interstitial lung disease.